Dr. Jennifer B. Valerin
Claim this profileUC Irvine Health/Chao Family Comprehensive Cancer Center
Expert in Pancreatic Cancer
Studies Lung Cancer
19 reported clinical trials
35 drugs studied
Area of expertise
1Pancreatic Cancer
Global LeaderStage IV
BRCA1 positive
BRCA2 positive
2Lung Cancer
Stage IV
HER2 positive
Stage III
Affiliated Hospitals
Clinical Trials Jennifer B. Valerin is currently running
Nivolumab + Ipilimumab + Sargramostim
for Advanced Melanoma
This phase II/III trial studies the side effects of nivolumab and ipilimumab when given together with or without sargramostim and to see how well they work in treating patients with stage III-IV melanoma that cannot be removed by surgery (unresectable) and that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). Immunotherapy with monoclonal antibodies, such as ipilimumab and nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Colony-stimulating factors, such as sargramostim, may increase the production of white blood cells. It is not yet known whether nivolumab and ipilimumab are more effective with or without sargramostim in treating patients with melanoma.
Recruiting1 award Phase 2 & 323 criteria
Durvalumab + Olaparib with Radiation
for Pancreatic Cancer
This phase I trial tests the safety and tolerability of olaparib in combination with durvalumab and radiation therapy in patients with pancreatic cancer that has spread to nearby tissue or lymph nodes (locally advanced) and cannot be removed by surgery (unresectable). Olaparib is an inhibitor of PARP, an enzyme that helps repair deoxyribonucleic acid (DNA) when it becomes damaged. Blocking PARP may help keep cancer cells from repairing their damaged DNA, causing them to die. PARP inhibitors are a type of targeted therapy. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Radiation therapy uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. The combination of targeted therapy with olaparib, immunotherapy with durvalumab and radiation therapy may stimulate an anti-tumor immune response and promote tumor control in locally advanced unresectable pancreatic cancer.
Recruiting1 award Phase 125 criteria
More about Jennifer B. Valerin
Clinical Trial Related5 years of experience running clinical trials · Led 19 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Jennifer B. Valerin has experience with
- Nivolumab
- Nab Paclitaxel
- Pembrolizumab
- Olaparib
- Gemcitabine
- Fluorouracil
Breakdown of trials Jennifer B. Valerin has run
Pancreatic Cancer
Melanoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jennifer B. Valerin specialize in?
Jennifer B. Valerin focuses on Pancreatic Cancer and Lung Cancer. In particular, much of their work with Pancreatic Cancer has involved Stage IV patients, or patients who are BRCA1 positive.
Is Jennifer B. Valerin currently recruiting for clinical trials?
Yes, Jennifer B. Valerin is currently recruiting for 9 clinical trials in Orange California. If you're interested in participating, you should apply.
Are there any treatments that Jennifer B. Valerin has studied deeply?
Yes, Jennifer B. Valerin has studied treatments such as Nivolumab, Nab paclitaxel, Pembrolizumab.
What is the best way to schedule an appointment with Jennifer B. Valerin?
Apply for one of the trials that Jennifer B. Valerin is conducting.
What is the office address of Jennifer B. Valerin?
The office of Jennifer B. Valerin is located at: UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California 92868 United States. This is the address for their practice at the UC Irvine Health/Chao Family Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.